Works matching IS 0008543X AND DT 2023 AND VI 129
Results: 519
Researchers identify two new subtypes of HPV‐associated head and neck cancers.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3842, doi. 10.1002/cncr.35123
- Publication type:
- Article
FDA approves new combined treatment for advanced prostate cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3841, doi. 10.1002/cncr.35122
- Publication type:
- Article
First person profile: Patricia M. LoRusso, DO: This researcher and clinician has conducted work in early‐phase trials that has led to the approval of several anticancer agents, all while keeping her focus on the patients she says make these trials possible
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3840, doi. 10.1002/cncr.35121
- By:
- Publication type:
- Article
Retraction: Yanjing Wu, Shupeng Liu, Hong Xin, Jing Jiang, Edward Younglai, Shuhan Sun, and Huilan Wang. Up‐regulation of microRNA‐145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells. Cancer 2011;117:3989‐3998
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3988, doi. 10.1002/cncr.35092
- Publication type:
- Article
Progress in precision pediatric surgical oncology.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3852, doi. 10.1002/cncr.35073
- By:
- Publication type:
- Article
Erratum to "JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer".
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3987, doi. 10.1002/cncr.35064
- Publication type:
- Article
Thank You to Reviewers 2023.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3989, doi. 10.1002/cncr.35046
- Publication type:
- Article
Top advances of the year: Pancreatic cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3843, doi. 10.1002/cncr.35031
- By:
- Publication type:
- Article
Fluorescent‐guided surgery and the use of indocyanine green sentinel lymph node mapping in the pediatric and young adult oncology population.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3962, doi. 10.1002/cncr.35023
- By:
- Publication type:
- Article
Ototoxicity associated with high‐dose carboplatin for patients with previously treated germ cell tumors.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3952, doi. 10.1002/cncr.34991
- By:
- Publication type:
- Article
A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3905, doi. 10.1002/cncr.34985
- By:
- Publication type:
- Article
A PI3K gene expression signature predicts for recurrence in early‐stage non–small cell lung cancer treated with stereotactic body radiation therapy.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3971, doi. 10.1002/cncr.34983
- By:
- Publication type:
- Article
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3884, doi. 10.1002/cncr.34982
- By:
- Publication type:
- Article
Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self‐reporting as Indigenous and non‐Indigenous.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3894, doi. 10.1002/cncr.34947
- By:
- Publication type:
- Article
Incidence, risk factors, and management of alpelisib‐associated hyperglycemia in metastatic breast cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3854, doi. 10.1002/cncr.34928
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3833, doi. 10.1002/cncr.33739
- Publication type:
- Article
Alcohol consumption and prognosis and survival in breast cancer survivors: The Pathways Study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3938, doi. 10.1002/cncr.34972
- By:
- Publication type:
- Article
Accounting for Medicaid expansion and regional policy and programs to advance equity in cancer prevention in the United States.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3915, doi. 10.1002/cncr.34956
- By:
- Publication type:
- Article
Diabetic severity and oncological outcomes of colorectal cancer following curative resection: A population‐based cohort study in Taiwan.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3928, doi. 10.1002/cncr.34975
- By:
- Publication type:
- Article
Persistence of patient‐detected breast cancer over time: 1990–2019.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3862, doi. 10.1002/cncr.34973
- By:
- Publication type:
- Article
Expert consensus‐based guidance on approaches to opioid management in individuals with advanced cancer‐related pain and nonmedical stimulant use.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3978, doi. 10.1002/cncr.34921
- By:
- Publication type:
- Article
Low TP53 variant allele frequency as a biomarker for anti‐programmed death (ligand) 1 monotherapy in lung adenocarcinoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3873, doi. 10.1002/cncr.34967
- By:
- Publication type:
- Article
Immunotherapy plus stereotactic radiation therapy improves event‐free survival in early‐stage non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3680, doi. 10.1002/cncr.35088
- Publication type:
- Article
Thymus removal in adults increases cancer risk and mortality.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3679, doi. 10.1002/cncr.35087
- By:
- Publication type:
- Article
Are multicancer early detection screening tests a hoped‐for breakthrough?: Although these tests have the potential to detect multiple cancer types earlier, research is underway to determine if their benefits outweigh their drawbacks.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3678, doi. 10.1002/cncr.35086
- By:
- Publication type:
- Article
What are the most effective exercise, physical activity and dietary interventions to improve body composition in women diagnosed with or at high‐risk of breast cancer? A systematic review and network meta‐analysis.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3697, doi. 10.1002/cncr.35043
- By:
- Publication type:
- Article
Outcome of Philadelphia chromosome‐positive chronic myeloid leukemia in the United States since the introduction of imatinib therapy—The Surveillance, Epidemiology, and End Results database, 2000–2019.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3805, doi. 10.1002/cncr.35038
- By:
- Publication type:
- Article
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3772, doi. 10.1002/cncr.35036
- By:
- Publication type:
- Article
Top advances of the year: Myeloproliferative neoplasms.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3685, doi. 10.1002/cncr.35028
- By:
- Publication type:
- Article
The reignition of the Cancer Moonshot: An opportunity missed?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3681, doi. 10.1002/cncr.35014
- By:
- Publication type:
- Article
Race‐inclusive and equitable access to immune checkpoint inhibitor therapy: What are the biggest hurdles?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3692, doi. 10.1002/cncr.35013
- By:
- Publication type:
- Article
Racial differences in serum chemokines in prostate cancer patients.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3783, doi. 10.1002/cncr.35012
- By:
- Publication type:
- Article
Oncology hospitalist impact on hospice utilization.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3797, doi. 10.1002/cncr.35008
- By:
- Publication type:
- Article
Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance).
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3724, doi. 10.1002/cncr.35007
- By:
- Publication type:
- Article
The utility of H2 receptor antagonists in preventing infusion‐related reactions to paclitaxel chemotherapy.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3815, doi. 10.1002/cncr.35006
- By:
- Publication type:
- Article
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3735, doi. 10.1002/cncr.35004
- By:
- Publication type:
- Article
Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3746, doi. 10.1002/cncr.34987
- By:
- Publication type:
- Article
Relationship between survivorship care plans and unmet information needs, quality of life, satisfaction with care, and propensity to engage with, and attend, follow‐up care.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3820, doi. 10.1002/cncr.34984
- By:
- Publication type:
- Article
The oncologic risk of magnetic resonance imaging‐targeted and systematic cores in patients treated with radical prostatectomy.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3790, doi. 10.1002/cncr.34981
- By:
- Publication type:
- Article
Quality of life after surgery for lower grade gliomas.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3761, doi. 10.1002/cncr.34980
- By:
- Publication type:
- Article
TRKing sarcomas for precision medicine: Seek, and ye shall find!
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3694, doi. 10.1002/cncr.34941
- By:
- Publication type:
- Article
Safety and efficacy of durvalumab after concurrent chemoradiation in Black patients with locally advanced non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3713, doi. 10.1002/cncr.34915
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3671, doi. 10.1002/cncr.33737
- Publication type:
- Article
HPV testing in older women may improve cervical cancer prevention.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 22, p. 3518, doi. 10.1002/cncr.35082
- Publication type:
- Article
Expanding rural‐area oncology service access through 340B Drug Pricing Program participation.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 22, p. 3517, doi. 10.1002/cncr.35081
- By:
- Publication type:
- Article
Targeting metabolic abnormality for advanced prostate cancer: The prodrug Platin‐L effectively targets the metabolic abnormality needed to make this cancer sensitive to cisplatin.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 22, p. 3516, doi. 10.1002/cncr.35080
- By:
- Publication type:
- Article
Insights into parent and adolescent patient understanding of genomic sequencing.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 22, p. 3519, doi. 10.1002/cncr.34996
- By:
- Publication type:
- Article
New era for myelofibrosis treatment with novel agents beyond Janus kinase‐inhibitor monotherapy: Focus on clinical development of BCL‐X<sub>L</sub>/BCL‐2 inhibition with navitoclax.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 22, p. 3535, doi. 10.1002/cncr.34986
- By:
- Publication type:
- Article
Advancing immunotherapy in small cell lung cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 22, p. 3525, doi. 10.1002/cncr.34977
- By:
- Publication type:
- Article
Promoting lung cancer screening of high‐risk patients by primary care providers.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 22, p. 3574, doi. 10.1002/cncr.34955
- By:
- Publication type:
- Article